About Allogene (ALLO)
Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more
- USD1.24
- USD1.29
- USD1.21
- USD3.78
- -7.50%
- --
- 1.17M
- 3.08M
- 280M
- 0.86
- -58.40%
Stock News
4 hours ago
As media reckons with strategic shifts, a new crop of leaders is coming into play
CNBC
4 hours ago
Ford’s stock takes a hit, as expected cost of large recall of SUVs is disclosed
MarketWatch
8 hours ago
Higher CPI Inflation In June Encourages Focus On Margins
SeekingAlpha
8 hours ago
Global Wealth Research - Quarterly Report: July 2025
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
